IVD Quality Control Market Size, Share, Growth Analysis, By Product and Service(Quality control products, data management solutions, and quality assurance services.), By Application(Clinical Chemistry, immunochemistry/immunoassay, hematology, molecular diagnostics), By Manufacturer type(Third-party control manufacturers, and original equipment manufacturers), By Region - Industry Forecast 2024-2031

Global IVD Quality Control Market size was valued at USD 1.10 billion in 2022 and is poised to grow from USD 1.11 billion in 2023 to USD 1.5 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031).

The growth of the global IVD quality control market is accredited to clinical laboratories, increasing geriatric population, increasing demand for external quality assessment programs, rising adoption of POC instruments in developed regions, and the increase in third-party quality control.

Increase in the global incidence of infectious illness, HIV, and malignancies that need innovative diagnostics for effective treatment and quality control for monitoring their performance. According to the Joint United Nations Program on HIV and AIDS, in 2019, an estimated 24.5 million HIV patients received antiretroviral medication. Fast diagnosis systems and rising demand for quality evolution support also propel the market growth.

The factors that hindered the global IVD quality control market include additional burdens associated with quality control on laboratories, unfavorable reimbursement scenario for IVD test, and lack of mandatory regulations for clinical laboratory accreditation in many emerging countries.

US IVD Quality Control Market  is poised to grow at a sustainable CAGR for the next forecast year.